North West England MRC Fellowships in Clinical Pharmacology and Therapeutics

在生命科学办公室最近的一份报告中，临床药理学被强调为对英国医疗保健和工业至关重要的专业。我们提出的计划建立在利物浦大学非常成功的临床药理学培训计划的基础上。我们独特的卖点是利物浦大学和曼彻斯特大学之间的合作，基于现有的MRC药物安全科学中心，并与20家制药公司（阿斯利康和葛兰素史克）和2个合同研究组织（ICON和药品评估单位）。我们专注于重要的学科领域，包括儿科，那里有一个根本需要改善儿童药物。该计划旨在确定最好的学生，为他们提供？没有墙？培训通过附件与我们的行业合作伙伴，以及良好的监督和指导安排，所有这些都提高了学生的学习经验。在4年内，我们将培养12名临床研究员进行博士学位;每个项目将根据个人及其临床培训量身定制。该计划将加强英国的临床药理学技能基础，使医疗保健、学术界、工业界、监管部门以及最终的本科生培训受益。

In a recent report from the Office for Life Sciences, Clinical Pharmacology was highlighted asa specialty vital for healthcare and industry in the UK. Our proposed scheme builds upon ahighly successful training programme in Clinical Pharmacology, based at the University ofLiverpool. Our unique selling point is the collaboration between the Universities of Liverpooland Manchester based on the existing MRC Centre for Drug Safety Science, and with 2pharmaceutical companies (AstraZeneca and GlaxoSmithKline) and 2 contract researchorganisations (ICON and Medicines Evaluation Unit). We focus on important subject areas,including paediatrics, where there is a fundamental need to improve drugs for children. Thescheme is designed to identify the best students, provide them with ?without walls? trainingthrough attachments with our industry partners, together with excellent supervision andmentoring arrangements, all of which enhance the student learning experience. Over 4years, we will train 12 clinical fellows to undertake PhDs; each project will be tailored to theindividual and their clinical training. The Clinical Pharmacology skills base in the UK will beenhanced by the scheme with benefit to healthcare, academia, industry, regulation andultimately undergraduate training.